Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways ...
A local nonprofit supporting those impacted by cancer is being recognized while also expanding its reach in the community.
Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used PARP inhibitors.
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, an investigational, systemically delivered immunotherapy that has ...
A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...
She emphasizes the importance of self-advocacy and giving oneself grace during survivorship. Support communities like ...
The FDA has granted Orphan Drug Designation to tovecimig (CTX-009) for the treatment of patients with biliary tract cancer ...
A large study of adult colonoscopies found sessile serrated lesion detection rate was significantly associated with lower risk for postcolonoscopy colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results